Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase 1, Randomized, Open Label, 2-way Crossover Study To Estimate The Effect Of Multiple Dose Pf-06651600 On The Pharmacokinetics Of Single Dose Oral Contraceptive Steroids In Healthy Female Subjects

Trial Profile

A Phase 1, Randomized, Open Label, 2-way Crossover Study To Estimate The Effect Of Multiple Dose Pf-06651600 On The Pharmacokinetics Of Single Dose Oral Contraceptive Steroids In Healthy Female Subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 24 Dec 2018

At a glance

  • Drugs PF 6651600 (Primary) ; Ethinylestradiol; Levonorgestrel
  • Indications Alopecia areata; Crohn's disease; Rheumatoid arthritis; Ulcerative colitis
  • Focus Pharmacokinetics
  • Sponsors Pfizer
  • Most Recent Events

    • 14 Dec 2018 Status changed from recruiting to completed.
    • 12 Nov 2018 Planned End Date changed from 26 Nov 2018 to 23 Nov 2018.
    • 02 Oct 2018 Planned End Date changed from 1 Nov 2018 to 26 Nov 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top